Omalizumab therapy was linked to improved inflammatory biomarkers and symptom scores after 16 weeks in patients with severe allergic asthma.

Tezspire (tezepelumab-ekko) is a monthly injection used to treat severe asthma. It was approved by the FDA in 2021 for use in addition to other asthma controlling medicines in people 12 and older.

Asthma care continues to develop, particularly in how treatment and long-term management are approached. This article outlines current treatment and management recommendations for patients aged 12 and ...

Allergies are one of the most common, but overlooked, conditions. With Spring in full swing, it's important to know the facts ...

Inhaling marijuana via smoking or vaping is associated with a significantly greater risk for asthma attacks among young adults in the US.

Adults between the ages of 18 and 57 who have suffered from an allergic disorder had a higher risk of high blood pressure, according to the research, which will be presented at the American College of ...

Scientists working in the School of Biochemistry and Immunology at the Trinity Biomedical Sciences Institute (TBSI) report they have uncovered a new strategy in mice for treating severe asthma. The ...

Spring and post-shelter exposure – cases are rising. A lingering runny nose, night cough and wheezing may signal allergy or ...

A Mendelian randomization analysis supported an increasing causal relationship between asthma and lung cancer risk, particularly in smokers and lung squamous cell carcinoma. Individuals with asthma ...

Though they’re separate conditions, allergic rhinitis and asthma are both atopic diseases. Allergies can trigger asthma, and having asthma can increase your risk for allergic rhinitis. Allergic ...